» Authors » Xin Yuan Liu

Xin Yuan Liu

Explore the profile of Xin Yuan Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 346
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding M, Lin B, Li T, Liu Y, Li Y, Zhou X, et al.
Oncotarget . 2015 Mar; 6(10):7686-700. PMID: 25797256
Androgen deprivation therapy in prostate cancer (PCa) causes neuroendocrine differentiation (NED) of prostatic adenocarcinomas (PAC) cells, leading to recurrence of PCa. Androgen-responsive genes involved in PCa progression including NED remain...
2.
Qi R, Liu X
Int J Biomed Sci . 2013 May; 2(3):211-6. PMID: 23674984
Caspase activation has been frequently viewed as synonymous with programmed cell death (PCcD); however, accumulating evidence showed that there existing caspase-independent PCcD pathways displaying morphologies that are not fully consistent...
3.
Xiao L, Wu Y, Qian J, Tan Y, Xie G, Zhang K, et al.
Cancer Biol Ther . 2010 Jun; 10(3):242-50. PMID: 20574150
Background: IL-24 (interleukin-24) is a promising, multi-functional anti-cancer agent able to selectively induce tumor cell apoptosis while sparing normal cells. Additionally, IL-24 can enhance the immune response to tumors and...
4.
Wei N, Fan J, Gu J, Liu X
Hum Gene Ther . 2010 Feb; 21(7):855-64. PMID: 20163249
Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24), identified by subtraction hybridization in the mid-1990s, is a potent gene therapeutic for cancer. Using a replication-deficient adenovirus as vector, it provokes apoptosis in diverse cancer...
5.
Fan J, Wei N, Ding M, Gu J, Liu X, Li B, et al.
Int J Cancer . 2009 Dec; 127(3):707-17. PMID: 19950222
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in Western male population. Previous studies have demonstrated that differential display code 3 (DD3 or DD3(PCA3)) is one of...
6.
Xiao T, Fan J, Huang H, Gu J, Li L, Liu X
Cell Res . 2009 Nov; 20(3):367-78. PMID: 19918267
Vascular endothelial cell growth inhibitor (VEGI) is a member of the tumor necrosis factor superfamily and plays an important role in vascular homeostasis. In this study, to investigate the anticancer...
7.
Zhong S, Yu D, Wang Y, Qiu S, Wu S, Liu X
Acta Oncol . 2009 Sep; 49(1):91-9. PMID: 19734998
Purpose: Oncolytic adenovirus such as ZD55 has become a promising anticancer agent for its efficient tumor-targeted replication and lysis capability. Armed with therapeutic gene IL-24 to generate a novel oncolytic...
8.
Wei N, Fan J, Gu J, He L, Tang W, Cao X, et al.
Biochem Biophys Res Commun . 2009 Aug; 388(2):234-9. PMID: 19653996
Safety and efficiency are equally important to be considered in developing oncolytic adenovirus. Previously, we have reported that ZD55, an oncolytic adenovirus with the deletion of E1B-55K gene, exhibited potent...
9.
He L, Wang Y, Xiao T, Zhang K, Li G, Gu J, et al.
Cancer Lett . 2009 Jul; 286(2):196-205. PMID: 19564073
Adeno-associated virus (AAV) has rapidly become a promising gene delivery vehicle for its excellent advantages of non-immunogenic, low pathogenicity and long-term gene expression in vivo. However, a major obstacle in...
10.
Li G, Li N, Zhang Y, Li X, Wang Y, Liu X, et al.
Int J Hematol . 2009 Apr; 89(5):611-7. PMID: 19377843
Altered glycosylation may be a hallmark of malignant transformation and cancer progression. In the work described, a specific mannose-binding lectin, Pinellia pedatisecta agglutinin (PPA), was genetically fused with the extracellular...